Asklepios secures early refinancing by placing new Schuldschein loan agreement
• Successful placement with existing and new investors
• Maturity profile extended by redeeming selected Schuldschein loan maturities
Asklepios Kliniken GmbH & Co. KGaA has secured early refinancing for selected Schuldschein loan agreement maturities for 2022 and 2024 to 2027 as part of a EUR 477.0 million Schuldschein loan issue. The new Schuldschein loan agreement with maturities of 5, 7 and 10 years was placed with existing and new investors using the digital Schuldschein platform vc trade.
As part of an exchange and increase offer, existing investors were able to prematurely extend or increase their Schuldschein commitment. Any new investors who were interested could also participate in the Asklepios Group Schuldschein loan agreement.
“Issuing the new Schuldschein loan agreement is part of our active maturity management and long-term financing strategy,” said Hafid Rifi, Chief Financial Officer of the Asklepios Group. “The Schuldschein loan agreement allowed us to further extend our volume-weighted average term of the maturity profile, optimize the medium to long-term distribution of the maturities and thus further strengthen the Asklepios Group’s financing profile,” added Hafid Rifi. “Especially given ongoing geopolitical uncertainty, the massive surge in inflation and extremely volatile capital markets, the considerable interest shown by investors represents a clear commitment to Asklepios’s business model. As well as the interest demonstrated by our existing investors, this is also made clear by the positive response to our offer among new investors.”
“The Schuldschein market has once again proven to be a more than resilient refinancing platform,” said Benedikt Brörmann, Head of Corporate Finance & Treasury at Asklepios. “The issue volume corresponds exactly to the amount needed for the early repayment of a number of outstanding Schuldschein tranches. In addition, the new Schuldschein helped us make further progress in harmonizing our Schuldschein documentation. Looking back, we found a good time frame for carrying out the transaction and can generate a very good result in terms of the volume, terms and conditions of the Schuldschein loan agreement.”
The placement of the Schuldschein loan agreement was managed by BNP Paribas, ING and Landesbank Baden-Württemberg as the arrangers. Asklepios’s legal adviser was Linklaters LLP.
Talk to us
Mirjam Constantin
Head of Group Reporting (Financial & ESG) | Manager Investor Relations
- type a message
- +49 61 74 90 11 66
- +49 61 74 90 11 10
Rune Hoffmann
Konzernbereichsleiter Unternehmenskommunikation & Marketing
About Asklepios
Asklepios Kliniken is one of the leading private operators of hospitals and healthcare facilities in Germany. The hospital group stands for highly qualified care for its patients, with a clear commitment to medical quality, innovation and social responsibility. On this basis, Asklepios has developed dynamically since it was founded almost 40 years ago. The Group now has more than 164 healthcare facilities across Germany, including acute care hospitals for all levels of care, university hospitals, specialist clinics, psychiatric and forensic facilities, rehabilitation clinics, nursing homes and medical centres. Around 3.5 million patients were treated at the Asklepios Group’s facilities in the 2023 financial year. The company has over 68,000 employees.